MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$202,937
Unit: Dollar
Positive Cash Flow Breakdown
Proceeds from sales and maturiti...
Stock compensation
Accrued expenses
Others
Negative Cash Flow Breakdown
Net loss
Purchase of short-term investmen...
Prepaid expenses and other curre...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-2,239,170
-2,096,837
-2,376,546
-2,276,311
Stock compensation
408,387
478,611
831,529
1,082,790
Depreciation
2,737
4,107
-
-
Amortization
20,325
6,736
6,152
5,473
Write off of inventory
-
-
16,380
-
Gain on sale of short-term investments
8,016
21,025
27,609
46,774
Return on investment in joint venture
-
-
0
864
Accounts receivable
-27,886
-755
35,833
-51,916
Accounts receivable- related party
-
-37,812
37,812
0
Prepaid expenses and other current assets
211,580
-3,838
66,463
53,040
Inventory
53,973
48,016
-12,372
-12,749
Accounts payable - related party
-
-
-
2,911
Accounts payable
71,349
-76,480
179,996
-168,228
Accrued expenses
218,239
-2,489
318,723
-47,973
Accrued expenses - related party
-
-
-
-34,000
Net cash used in operating activities
-1,801,628
-1,712,988
-1,148,022
-1,466,257
Sale of short-term investments
-
5,589,606
9,478,000
13,546,000
Proceeds from sales and maturities of short-term investments
-8,098,254
-
-
-
Purchase of short-term investments
1,000,536
4,000,654
8,755,181
11,901,824
Purchase of equipment
0
49,276
-
-
Purchase of patents
28,411
14,065
13,609
11,118
Purchase of trademarks
19,375
15,932
20,030
16,887
Net cash provided by (used in) investing activities
1,460,326
1,509,679
689,180
1,625,012
Sale of common stock for cash, net of financing fees
-
-
0
0
Net proceeds from sales of common stock under atm program
138,365
756,421
523,550
-
Net cash provided by financing activities
138,365
756,421
523,550
0
Net increase (decrease) in cash and cash equivalents
-202,937
553,112
64,708
158,755
Cash and cash equivalents - beginning of period
1,207,895
654,783
590,075
574,485
Cash and cash equivalents - end of period
1,004,958
1,207,895
654,783
590,075
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from sales and
maturities of short-term...
-$8,098,254
Net proceeds from
sales of common stock...
$138,365
Net cash provided by
(used in) investing...
$1,460,326
(159.70%↑ Y/Y)
Net cash provided by
financing activities
$138,365
(-97.02%↓ Y/Y)
Canceled cashflow
$6,637,928
Net increase
(decrease) in cash and cash...
-$202,937
(-41.75%↓ Y/Y)
Canceled cashflow
$1,598,691
Stock compensation
$408,387
(-66.22%↓ Y/Y)
Accrued expenses
$218,239
(1264.50%↑ Y/Y)
Accounts payable
$71,349
(-7.17%↓ Y/Y)
Accounts receivable
-$27,886
(-155.99%↓ Y/Y)
Amortization
$20,325
(105.05%↑ Y/Y)
Depreciation
$2,737
something is missing
-$5,589,606
Purchase of short-term
investments
$1,000,536
(-95.02%↓ Y/Y)
Purchase of patents
$28,411
(-19.32%↓ Y/Y)
Purchase of trademarks
$19,375
(119.15%↑ Y/Y)
Net cash used in
operating activities
-$1,801,628
(23.12%↑ Y/Y)
Canceled cashflow
$748,923
Net loss
-$2,239,170
(37.27%↑ Y/Y)
Prepaid expenses and
other current assets
$211,580
(522.43%↑ Y/Y)
Inventory
$53,973
(3464.90%↑ Y/Y)
Gain on sale of
short-term investments
$8,016
(-84.75%↓ Y/Y)
Buy us a coffee
Nexalin Technology, Inc. (NXL)
Nexalin Technology, Inc. (NXL)